(Q42174779)

18 October 2017

Low dose carvedilol inhibits progression of heart failure in rats with dilated cardiomyopathy (English)

1 reference

18 October 2017

0 references

1 reference

K Watanabe

1

1 reference

18 October 2017

Y Ohta

2

1 reference

18 October 2017

M Nakazawa

3

1 reference

18 October 2017

H Higuchi

4

1 reference

18 October 2017

G Hasegawa

5

1 reference

18 October 2017

M Naito

6

1 reference

18 October 2017

K Fuse

7

1 reference

18 October 2017

M Ito

8

1 reference

18 October 2017

S Hirono

9

1 reference

18 October 2017

N Tanabe

10

1 reference

18 October 2017

H Hanawa

11

1 reference

18 October 2017

K Kato

12

1 reference

18 October 2017

M Kodama

13

1 reference

18 October 2017

Y Aizawa

14

1 reference

18 October 2017

language of work or name

English

0 references

publication date

1 August 2000

1 reference

British Journal of Pharmacology

18 October 2017

1 reference

18 October 2017

130

1 reference

18 October 2017

7

1 reference

18 October 2017

1489-1495

1 reference

Carvedilol, a novel multiple action antihypertensive agent with antioxidant activity and the potential for myocardial and vascular protection

18 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1572210

Carvedilol, a cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injury

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1572210

Comparison between carvedilol and captopril in rats with partial ablation-induced chronic renal failure

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1572210

beta-adrenergic receptor regulation and left ventricular function in idiopathic dilated cardiomyopathy

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1572210

Oxygen free radicals and congestive heart failure

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1572210

Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1572210

Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study Group

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1572210

Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1572210

Chronic carvedilol reduces mortality and renal damage in hypertensive stroke-prone rats.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1572210

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1572210

Elevated breath pentane in heart failure reduced by free radical scavenger.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1572210

An animal model of congestive (dilated) cardiomyopathy: dilatation and hypertrophy of the heart in the chronic stage in DBA/2 mice with myocarditis caused by encephalomyocarditis virus

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1572210

A randomized trial of low-dose beta-blockade therapy for idiopathic dilated cardiomyopathy

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1572210

A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1572210

The pharmacology of carvedilol

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1572210

Studies on the mechanism of arterial vasodilation produced by the novel antihypertensive agent, carvedilol

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1572210

Adrenoceptor-Blocking Activity and Cardiohemodynamic Effects of Carvedilol in Animals

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1572210

Cardioprotective effects of carvedilol, a novel beta adrenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: comparison with propranolol

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1572210

Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1572210

SB 211475, a metabolite of carvedilol, a novel antihypertensive agent, is a potent antioxidant.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1572210

A potent antioxidant, SB209995, inhibits oxygen-radical-mediated lipid peroxidation and cytotoxicity

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1572210

Carvedilol inhibits vascular smooth muscle cell proliferation.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1572210

Idiopathic dilated cardiomyopathy in the young: clinical profile and natural history

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1572210

Carvedilol blocks the repolarizing K+ currents and the L-type Ca2+ current in rabbit ventricular myocytes

17 August 2018

1 reference

12 December 2020

Giant cell versus lymphocytic myocarditis. A comparison of their clinical features and long-term outcomes

1 reference

12 December 2020

An immunosuppressant compound, FK-506, prevents the progression of autoimmune myocarditis in rats

1 reference

12 December 2020

Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome

1 reference

12 December 2020

Atrial natriuretic peptide elevation in congestive heart failure in the human

1 reference

12 December 2020

Plasma concentrations of alpha-human atrial natriuretic polypeptide and cyclic GMP in patients with heart disease

1 reference

12 December 2020

Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients

1 reference

12 December 2020

Rat dilated cardiomyopathy after autoimmune giant cell myocarditis

1 reference

12 December 2020

Carvedilol, a new vasodilating beta-adrenoceptor blocker, inhibits oxidation of low-density lipoproteins by vascular smooth muscle cells and prevents leukocyte adhesion to smooth muscle cells

1 reference

12 December 2020

Inhibition of Human Vascular Smooth Muscle Cell Proliferation by the Novel Multiple-Action Antihypertensive Agent Carvedilol

1 reference

12 December 2020

Ethanol ingestion on allylamine-induced experimental subendocardial fibrosis

1 reference

12 December 2020

Expression of inducible nitric oxide synthase in rat experimental autoimmune myocarditis with special reference to changes in cardiac hemodynamics

1 reference

12 December 2020

Carvedilol prevents severe hypertensive cardiomyopathy and remodeling

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJP.0703450

1 reference

18 October 2017

1 reference

18 October 2017

PubMed publication ID

10928949

1 reference